EndoTex Interventional Systems, Inc., a development stage medical device company, engages in the development and manufacture of
EndoTex Interventional Systems, Inc., a development stage medical device company, engages in the development and manufacture of less-invasive medical devices for use in the vascular system. It provides solutions for treating carotid artery disease. The company was founded in 1995 and is based in Cupertino, California. As of January 4, 2007, EndoTex Interventional Systems, Inc. is a subsidiary of Boston Scientific Corp.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 26, 2001 | Series E | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Boston Scientific | — | Series E |